Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphatase binding	KIFAP3 PPP1R9A SFI1 SIRPB1 SIRPA CDH5 PTK2	8.40e-05	264	79	7	GO:0019902
GeneOntologyMolecularFunction	protein phosphatase binding	KIFAP3 PPP1R9A SIRPB1 SIRPA CDH5 PTK2	1.85e-04	210	79	6	GO:0019903
GeneOntologyMolecularFunction	taste receptor activity	TAS1R2 TAS2R19 TAS2R50	2.99e-04	33	79	3	GO:0008527
GeneOntologyBiologicalProcess	negative regulation of chemokine (C-C motif) ligand 5 production	SIRPB1 SIRPA MUL1	4.13e-06	9	77	3	GO:0071650
GeneOntologyBiologicalProcess	regulation of chemokine (C-C motif) ligand 5 production	SIRPB1 SIRPA MUL1	2.20e-05	15	77	3	GO:0071649
GeneOntologyBiologicalProcess	chemokine (C-C motif) ligand 5 production	SIRPB1 SIRPA MUL1	2.71e-05	16	77	3	GO:0071609
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of taste	RTP3 TAS1R2 TAS2R19 TAS2R50	3.63e-05	50	77	4	GO:0050912
GeneOntologyBiologicalProcess	negative regulation of I-kappaB phosphorylation	SIRPB1 SIRPA	8.21e-05	4	77	2	GO:1903720
GeneOntologyBiologicalProcess	sensory perception of taste	RTP3 TAS1R2 TAS2R19 TAS2R50	1.37e-04	70	77	4	GO:0050909
GeneOntologyBiologicalProcess	negative regulation of macrophage inflammatory protein 1 alpha production	SIRPB1 SIRPA	1.37e-04	5	77	2	GO:0071641
GeneOntologyCellularComponent	vacuolar membrane	ABCA2 TPCN2 SZT2 RPTOR VPS41 TMEM138 FLCN TM4SF5 ABCC10	1.36e-04	507	80	9	GO:0005774
GeneOntologyCellularComponent	lysosomal membrane	ABCA2 TPCN2 SZT2 RPTOR VPS41 FLCN TM4SF5 ABCC10	3.86e-04	462	80	8	GO:0005765
GeneOntologyCellularComponent	lytic vacuole membrane	ABCA2 TPCN2 SZT2 RPTOR VPS41 FLCN TM4SF5 ABCC10	3.86e-04	462	80	8	GO:0098852
GeneOntologyCellularComponent	cortical actin cytoskeleton	SPTBN5 PPP1R9A SPTBN1 ACTR2	4.48e-04	93	80	4	GO:0030864
GeneOntologyCellularComponent	spectrin	SPTBN5 SPTBN1	5.12e-04	9	80	2	GO:0008091
GeneOntologyCellularComponent	cilium	SPTBN5 KIFAP3 C2CD3 FBXL13 DNAH10 TMEM138 FLCN TAS2R19 TAS2R50 NPHP4 PTK2	6.03e-04	898	80	11	GO:0005929
GeneOntologyCellularComponent	vacuole	ABCA2 TPCN2 MAN2B2 SZT2 RPTOR VPS41 TMEM138 FLCN TM4SF5 ACTR2 ABCC10	6.91e-04	913	80	11	GO:0005773
GeneOntologyCellularComponent	photoreceptor connecting cilium	SPTBN5 KIFAP3 NPHP4	8.25e-04	48	80	3	GO:0032391
GeneOntologyCellularComponent	lysosome	ABCA2 TPCN2 MAN2B2 SZT2 RPTOR VPS41 FLCN TM4SF5 ACTR2 ABCC10	1.03e-03	811	80	10	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	ABCA2 TPCN2 MAN2B2 SZT2 RPTOR VPS41 FLCN TM4SF5 ACTR2 ABCC10	1.03e-03	811	80	10	GO:0000323
GeneOntologyCellularComponent	cortical cytoskeleton	SPTBN5 PPP1R9A SPTBN1 ACTR2	1.52e-03	129	80	4	GO:0030863
Domain	ATM/Tel1	SMG1 ATM	1.72e-05	2	78	2	IPR015519
Domain	FATC	SMG1 ATM	1.71e-04	5	78	2	PF02260
Domain	FAT	SMG1 ATM	2.55e-04	6	78	2	PS51189
Domain	FATC	SMG1 ATM	2.55e-04	6	78	2	PS51190
Domain	FATC_dom	SMG1 ATM	2.55e-04	6	78	2	IPR003152
Domain	PIK_FAT	SMG1 ATM	2.55e-04	6	78	2	IPR014009
Domain	FATC	SMG1 ATM	2.55e-04	6	78	2	SM01343
Domain	PH_dom-spectrin-type	SPTBN5 SPTBN1	6.08e-04	9	78	2	IPR001605
Domain	NCD3G	TAS1R2 GRM8	1.30e-03	13	78	2	PF07562
Domain	GPCR_3_9-Cys_dom	TAS1R2 GRM8	1.30e-03	13	78	2	IPR011500
Domain	GPCR_3_CS	TAS1R2 GRM8	1.52e-03	14	78	2	IPR017979
Domain	PI3/4_kinase_CS	SMG1 ATM	1.75e-03	15	78	2	IPR018936
Domain	TLC	TRAM2 TLCD2	1.99e-03	16	78	2	PS50922
Domain	TLC	TRAM2 TLCD2	1.99e-03	16	78	2	SM00724
Domain	-	SMG1 ATM	1.99e-03	16	78	2	1.10.1070.11
Domain	TRAM_LAG1_CLN8	TRAM2 TLCD2	1.99e-03	16	78	2	PF03798
Domain	TLC-dom	TRAM2 TLCD2	1.99e-03	16	78	2	IPR006634
Domain	PI3Kc	SMG1 ATM	1.99e-03	16	78	2	SM00146
Domain	PI3/4_kinase_cat_dom	SMG1 ATM	2.52e-03	18	78	2	IPR000403
Domain	PI3_PI4_kinase	SMG1 ATM	2.52e-03	18	78	2	PF00454
Domain	PI3_4_KINASE_3	SMG1 ATM	2.52e-03	18	78	2	PS50290
Domain	PI3_4_KINASE_1	SMG1 ATM	2.52e-03	18	78	2	PS00915
Domain	PI3_4_KINASE_2	SMG1 ATM	2.52e-03	18	78	2	PS00916
Domain	AAA+_ATPase	MMAA ABCA2 DNAH10 ABCC10	3.11e-03	144	78	4	IPR003593
Domain	AAA	MMAA ABCA2 DNAH10 ABCC10	3.11e-03	144	78	4	SM00382
Domain	GPCR_3	TAS1R2 GRM8	3.43e-03	21	78	2	IPR000337
Domain	SRCR	CD163L1 LOXL4	3.43e-03	21	78	2	PF00530
Domain	7tm_3	TAS1R2 GRM8	3.77e-03	22	78	2	PF00003
Domain	G_PROTEIN_RECEP_F3_2	TAS1R2 GRM8	3.77e-03	22	78	2	PS00980
Domain	G_PROTEIN_RECEP_F3_3	TAS1R2 GRM8	3.77e-03	22	78	2	PS00981
Domain	G_PROTEIN_RECEP_F3_1	TAS1R2 GRM8	3.77e-03	22	78	2	PS00979
Domain	G_PROTEIN_RECEP_F3_4	TAS1R2 GRM8	3.77e-03	22	78	2	PS50259
Domain	GPCR_3_C	TAS1R2 GRM8	3.77e-03	22	78	2	IPR017978
Domain	Actinin_actin-bd_CS	SPTBN5 SPTBN1	4.12e-03	23	78	2	IPR001589
Domain	Spectrin	SPTBN5 SPTBN1	4.12e-03	23	78	2	PF00435
Domain	ACTININ_2	SPTBN5 SPTBN1	4.12e-03	23	78	2	PS00020
Domain	ACTININ_1	SPTBN5 SPTBN1	4.12e-03	23	78	2	PS00019
Domain	tRNA-bd_arm	KIAA0408 VARS1	4.48e-03	24	78	2	IPR010978
Domain	SR	CD163L1 LOXL4	4.85e-03	25	78	2	SM00202
Domain	-	CD163L1 LOXL4	4.85e-03	25	78	2	3.10.250.10
Domain	SRCR_1	CD163L1 LOXL4	5.24e-03	26	78	2	PS00420
Domain	TAS2R	TAS2R19 TAS2R50	5.24e-03	26	78	2	PF05296
Domain	SRCR_2	CD163L1 LOXL4	5.24e-03	26	78	2	PS50287
Domain	SRCR-like_dom	CD163L1 LOXL4	5.24e-03	26	78	2	IPR017448
Pathway	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	TAS1R2 TAS2R19 TAS2R50 GRM8	2.14e-05	37	63	4	MM15067
Pathway	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	TAS1R2 TAS2R19 TAS2R50 GRM8	2.65e-05	39	63	4	M793
Pathway	REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS	SIRPB1 SIRPA PTK2	4.57e-05	16	63	3	M925
Pubmed	Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.	SMG1 RPTOR ATM	2.13e-06	11	83	3	20427287
Pubmed	SMG1 heterozygosity exacerbates haematopoietic cancer development in Atm null mice by increasing persistent DNA damage and oxidative stress.	SMG1 ATM	5.63e-06	2	83	2	31565865
Pubmed	Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice.	USP34 ATM	5.63e-06	2	83	2	37043976
Pubmed	Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.	IL32 PTK2	5.63e-06	2	83	2	22203669
Pubmed	hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress.	SMG1 ATM	5.63e-06	2	83	2	18332866
Pubmed	Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells.	TM4SF5 PTK2	5.63e-06	2	83	2	23077174
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 ABCA2 C2CD3 TMEM120B SZT2 RPTOR POLG THAP8 FLCN SFI1 NPHP4 ABCC10	1.21e-05	1105	83	12	35748872
Pubmed	SIRPα maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis.	SIRPB1 SIRPA	1.69e-05	3	83	2	36202053
Pubmed	Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes.	SIRPB1 SIRPA	1.69e-05	3	83	2	15034021
Pubmed	Non-Hematopoietic and Hematopoietic SIRPα Signaling Differently Regulates Murine B Cell Maturation in Bone Marrow and Spleen.	SIRPB1 SIRPA	1.69e-05	3	83	2	26222253
Pubmed	Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1.	SIRPB1 SIRPA	1.69e-05	3	83	2	12167615
Pubmed	Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk.	SIRPB1 SIRPA	1.69e-05	3	83	2	31507080
Pubmed	Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex.	ACTR2 PTK2	1.69e-05	3	83	2	17721515
Pubmed	Involvement of signal regulatory protein α, a negative regulator of Toll-like receptor signaling, in impairing the MyD88-independent pathway and intracellular killing of Burkholderia pseudomallei-infected mouse macrophages.	SIRPB1 SIRPA	1.69e-05	3	83	2	22988019
Pubmed	Hypothermia-induced tyrosine phosphorylation of SIRPα in the brain.	SIRPB1 SIRPA	1.69e-05	3	83	2	22468987
Pubmed	Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha.	SIRPB1 SIRPA	1.69e-05	3	83	2	34917090
Pubmed	Effect of Serum Deprivation Stress on Signal Induction Regulatory Protein-Alpha (SIRP-Alpha)-Mediated Erythrophagocytosis by Macrophages.	SIRPB1 SIRPA	1.69e-05	3	83	2	30894504
Pubmed	Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha.	SIRPB1 SIRPA	1.69e-05	3	83	2	19667119
Pubmed	SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors.	SIRPB1 SIRPA	1.69e-05	3	83	2	28669759
Pubmed	Variation in telangiectasia predisposing genes is associated with overall radiation toxicity.	ATM ENG	1.69e-05	3	83	2	22677372
Pubmed	SIRPα controls the activity of the phagocyte NADPH oxidase by restricting the expression of gp91(phox).	SIRPB1 SIRPA	1.69e-05	3	83	2	23022485
Pubmed	Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity.	SIRPB1 SIRPA	1.69e-05	3	83	2	29158380
Pubmed	Lack of non-hematopoietic SIRPα signaling disturbs the splenic marginal zone architecture resulting in accumulation and displacement of marginal zone B cells.	SIRPB1 SIRPA	1.69e-05	3	83	2	25817792
Pubmed	Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.	SIRPB1 SIRPA	1.69e-05	3	83	2	12134038
Pubmed	Central nervous system antigen P84 can serve as a substrate for neurite outgrowth.	SIRPB1 SIRPA	1.69e-05	3	83	2	2303162
Pubmed	SHPS-1 promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages.	SIRPB1 SIRPA	1.69e-05	3	83	2	16141346
Pubmed	Deletion of SIRPα (signal regulatory protein-α) promotes phagocytic clearance of myelin debris in Wallerian degeneration, axon regeneration, and recovery from nerve injury.	SIRPB1 SIRPA	1.69e-05	3	83	2	31883525
Pubmed	Signal regulatory protein α is associated with tumor-polarized macrophages phenotype switch and plays a pivotal role in tumor progression.	SIRPB1 SIRPA	1.69e-05	3	83	2	23504854
Pubmed	SIRPα signaling regulates podocyte structure and function.	SIRPB1 SIRPA	1.69e-05	3	83	2	23842779
Pubmed	Essential roles of SIRPα in homeostatic regulation of skin dendritic cells.	SIRPB1 SIRPA	1.69e-05	3	83	2	20955735
Pubmed	A role for SHPS-1/SIRPalpha in Concanavalin A-dependent production of MMP-9.	SIRPB1 SIRPA	1.69e-05	3	83	2	17825046
Pubmed	SIRPα deficiency accelerates the pathologic process in models of Parkinson disease.	SIRPB1 SIRPA	1.69e-05	3	83	2	31322787
Pubmed	Soluble SIRP-Alpha Promotes Murine Acute Lung Injury Through Suppressing Macrophage Phagocytosis.	SIRPB1 SIRPA	1.69e-05	3	83	2	35634325
Pubmed	The Rho kinase pathway regulates the migration of dendritic cells through SIRP-α.	SIRPB1 SIRPA	1.69e-05	3	83	2	22391241
Pubmed	The murine P84 neural adhesion molecule is SHPS-1, a member of the phosphatase-binding protein family.	SIRPB1 SIRPA	1.69e-05	3	83	2	9348339
Pubmed	Targeting SIRP-α protects from type 2-driven allergic airway inflammation.	SIRPB1 SIRPA	1.69e-05	3	83	2	21108471
Pubmed	Mutational analysis of the mechanism of negative regulation by SRC homology 2 domain-containing protein tyrosine phosphatase substrate-1 of phagocytosis in macrophages.	SIRPB1 SIRPA	1.69e-05	3	83	2	16920950
Pubmed	Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the induction of Langerhans cell maturation.	SIRPB1 SIRPA	1.69e-05	3	83	2	17109464
Pubmed	Signal regulatory protein α negatively regulates mast-cell activation following FcεRI aggregation.	SIRPB1 SIRPA	1.69e-05	3	83	2	23504624
Pubmed	Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPα inhibitory signaling in mice.	SIRPB1 SIRPA	1.69e-05	3	83	2	23472187
Pubmed	SIRP/CD47 signaling in neurological disorders.	SIRPB1 SIRPA	1.69e-05	3	83	2	25795378
Pubmed	Signal regulatory protein alpha (SIRPα) regulates the homeostasis of CD103(+) CD11b(+) DCs in the intestinal lamina propria.	SIRPB1 SIRPA	1.69e-05	3	83	2	25236797
Pubmed	Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injury.	SIRPB1 SIRPA	1.69e-05	3	83	2	31370677
Pubmed	A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression.	SIRPB1 SIRPA	1.69e-05	3	83	2	30770827
Pubmed	Signal regulatory protein α protects podocytes through promoting autophagic activity.	SIRPB1 SIRPA	1.69e-05	3	83	2	30888336
Pubmed	Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responses.	SIRPB1 SIRPA	1.69e-05	3	83	2	38758648
Pubmed	Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration.	SIRPB1 SIRPA	1.69e-05	3	83	2	33795678
Pubmed	Requirement of SIRPα for protective immunity against Leishmania major.	SIRPB1 SIRPA	1.69e-05	3	83	2	20854790
Pubmed	Resistance to experimental autoimmune encephalomyelitis and impaired T cell priming by dendritic cells in Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 mutant mice.	SIRPB1 SIRPA	1.69e-05	3	83	2	17617577
Pubmed	BIT, an immune antigen receptor-like molecule in the brain.	SIRPB1 SIRPA	1.69e-05	3	83	2	9271230
Pubmed	Gene structure of mouse BIT/SHPS-1.	SIRPB1 SIRPA	1.69e-05	3	83	2	10585853
Pubmed	EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility.	PTK2 EPHA1	1.69e-05	3	83	2	19118217
Pubmed	Comparison of macrophage phenotype between decidua basalis and decidua parietalis by flow cytometry.	MRC1 ENG	1.69e-05	3	83	2	18353434
Pubmed	Expression of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 in pancreatic beta-Cells and its role in promotion of insulin secretion and protection against diabetes.	SIRPB1 SIRPA	1.69e-05	3	83	2	18635660
Pubmed	Tyrosine phosphorylation of the transmembrane protein SIRPα: Sensing synaptic activity and regulating ectodomain cleavage for synapse maturation.	SIRPB1 SIRPA	1.69e-05	3	83	2	29914984
Pubmed	SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility.	SIRPB1 SIRPA	1.69e-05	3	83	2	11118207
Pubmed	Intratumoral SIRPα-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy.	SIRPB1 SIRPA	1.69e-05	3	83	2	34050181
Pubmed	Ectodomain shedding of SHPS-1 and its role in regulation of cell migration.	SIRPB1 SIRPA	1.69e-05	3	83	2	15123722
Pubmed	SIRPα+ dendritic cells promote the development of fibroblastic reticular cells in murine peripheral lymph nodes.	SIRPB1 SIRPA	1.69e-05	3	83	2	31099900
Pubmed	Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.	SIRPB1 SIRPA	1.69e-05	3	83	2	33074246
Pubmed	Resistance to collagen-induced arthritis in SHPS-1 mutant mice.	SIRPB1 SIRPA	1.69e-05	3	83	2	18455510
Pubmed	Regulation of Phagocyte Migration by Signal Regulatory Protein-Alpha Signaling.	SIRPB1 SIRPA	1.69e-05	3	83	2	26057870
Pubmed	Essential roles of SHPS-1 in induction of contact hypersensitivity of skin.	SIRPB1 SIRPA	1.69e-05	3	83	2	18809435
Pubmed	Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function.	SIRPB1 SIRPA	1.69e-05	3	83	2	19223164
Pubmed	Negative regulation by SHPS-1 of Toll-like receptor-dependent proinflammatory cytokine production in macrophages.	SIRPB1 SIRPA	1.69e-05	3	83	2	18233962
Pubmed	Suppression of SHP-1 promotes corticospinal tract sprouting and functional recovery after brain injury.	SIRPB1 SIRPA	1.69e-05	3	83	2	23559001
Pubmed	The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways.	SMG1 ATM	1.69e-05	3	83	2	15279777
Pubmed	SHPS-1 deficiency induces robust neuroprotection against experimental stroke by attenuating oxidative stress.	SIRPB1 SIRPA	1.69e-05	3	83	2	22671569
Pubmed	Endothelial SIRPα signaling controls VE-cadherin endocytosis for thymic homing of progenitor cells.	SIRPB1 SIRPA	1.69e-05	3	83	2	35511221
Pubmed	Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells.	SIRPB1 SIRPA	1.69e-05	3	83	2	17475843
Pubmed	Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice.	SIRPB1 SIRPA	1.69e-05	3	83	2	12742627
Pubmed	Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs.	SIRPB1 SIRPA	1.69e-05	3	83	2	25818708
Pubmed	Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.	LOXL4 PTK2	1.69e-05	3	83	2	30704479
Pubmed	DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.	MRC1 PAPPA SIRPB1 SIRPA ENG	2.63e-05	145	83	5	21308776
Pubmed	Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.	SPTBN5 SPTBN1 PTK2	2.90e-05	25	83	3	8493579
Pubmed	SIRPα Mediates IGF1 Receptor in Cardiomyopathy Induced by Chronic Kidney Disease.	SIRPB1 SIRPA	3.37e-05	4	83	2	35722884
Pubmed	Macrophages require Skap2 and Sirpα for integrin-stimulated cytoskeletal rearrangement.	SIRPB1 SIRPA	3.37e-05	4	83	2	22976304
Pubmed	Signal-regulatory protein alpha is an anti-viral entry factor targeting viruses using endocytic pathways.	SIRPB1 SIRPA	3.37e-05	4	83	2	34097709
Pubmed	TLR5 mediates CD172α(+) intestinal lamina propria dendritic cell induction of Th17 cells.	SIRPB1 SIRPA	3.37e-05	4	83	2	26907705
Pubmed	Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia.	SIRPB1 SIRPA	3.37e-05	4	83	2	19771158
Pubmed	Inflammation Unrestrained by SIRPα Induces Secondary Hemophagocytic Lymphohistiocytosis Independent of IFN-γ.	SIRPB1 SIRPA	3.37e-05	4	83	2	33028619
Pubmed	Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages.	SIRPB1 SIRPA	3.37e-05	4	83	2	26085683
Pubmed	Endoglin expression level discriminates long-term hematopoietic from short-term clonogenic progenitor cells in the aorta.	ENG CDH5	3.37e-05	4	83	2	22271899
Pubmed	Abnormal chemokine-induced responses of immature and mature hematopoietic cells from motheaten mice implicate the protein tyrosine phosphatase SHP-1 in chemokine responses.	SIRPB1 SIRPA	3.37e-05	4	83	2	10477552
Pubmed	'Clustering' SIRPα into the plasma membrane lipid microdomains is required for activated monocytes and macrophages to mediate effective cell surface interactions with CD47.	SIRPB1 SIRPA	3.37e-05	4	83	2	24143245
Pubmed	Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection.	SIRPB1 SIRPA	3.37e-05	4	83	2	32294445
Pubmed	Polymorphism in the innate immune receptor SIRPα controls CD47 binding and autoimmunity in the nonobese diabetic mouse.	SIRPB1 SIRPA	3.37e-05	4	83	2	25305319
Pubmed	Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-α) on phagocytes.	SIRPB1 SIRPA	3.37e-05	4	83	2	21401967
Pubmed	Tethering of apoptotic cells to phagocytes through binding of CD47 to Src homology 2 domain-bearing protein tyrosine phosphatase substrate-1.	SIRPB1 SIRPA	3.37e-05	4	83	2	14634079
Pubmed	Polymorphism of TAS2R3, TAS2R5, TAS2R19, and TAS2R50 genes and bitter food intake frequency inelderly woman.	TAS2R19 TAS2R50	3.37e-05	4	83	2	32227702
Pubmed	CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction.	SIRPB1 SIRPA	3.37e-05	4	83	2	22042861
Pubmed	Membrane mobility and clustering of Integrin Associated Protein (IAP, CD47)--major differences between mouse and man and implications for signaling.	SIRPB1 SIRPA	3.37e-05	4	83	2	16697668
Pubmed	An essential role for the association of CD47 to SHPS-1 in skeletal remodeling.	SIRPB1 SIRPA	3.37e-05	4	83	2	21638321
Pubmed	Surfactant protein D prevents mucin overproduction in airway goblet cells via SIRPα.	SIRPB1 SIRPA	3.37e-05	4	83	2	38245585
Pubmed	Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model.	SIRPB1 SIRPA	3.37e-05	4	83	2	37095207
Pubmed	Distinct pattern of allelic loss and inactivation of cadherin 1 and 5 genes in mammary carcinomas arising in p53(+/-) mice.	ATM CDH5	3.37e-05	4	83	2	17327688
Pubmed	Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1.	RPTOR FLCN	3.37e-05	4	83	2	35420934
Pubmed	CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development.	SIRPB1 SIRPA	3.37e-05	4	83	2	30308165
Pubmed	High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages.	SIRPB1 SIRPA	3.37e-05	4	83	2	9712903
Pubmed	The FBXO32/ATR/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.	ATM FBXO32	3.37e-05	4	83	2	37227155
GeneFamily	CD molecules\|V-set domain containing\|C1-set domain containing\|Signal regulatory proteins	SIRPB1 SIRPA	8.38e-05	5	53	2	747
GeneFamily	EF-hand domain containing\|Spectrins	SPTBN5 SPTBN1	1.75e-04	7	53	2	1113
GeneFamily	TLC domain containing	TRAM2 TLCD2	3.74e-04	10	53	2	1374
GeneFamily	Sterile alpha motif domain containing	PPFIBP2 PPP1R9A EPHA1	2.19e-03	88	53	3	760
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	MRC1 CD163L1	2.82e-03	27	53	2	1253
GeneFamily	Taste 2 receptors	TAS2R19 TAS2R50	5.83e-03	39	53	2	1162
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	MRC1 SIRPB1 SIRPA ENG CDH5	5.83e-03	394	53	5	471
GeneFamily	C1-set domain containing	SIRPB1 SIRPA	6.73e-03	42	53	2	591
GeneFamily	C-type lectin domain family	MRC1 CLEC19A	8.38e-03	47	53	2	494
Coexpression	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	USP34 SMG1 BPTF SPTBN1 SFI1 ATM PTK2	2.37e-06	189	83	7	M3112
ToppCell	droplet-Heart-nan-24m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 MMAA ABCA2 FBXL13 PPFIBP2	1.20e-05	159	83	5	7ad3a91d29639b32f6264c91f401c14a35469ac0
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	USP34 SMG1 SPTBN1 SFI1 ATM	1.32e-05	162	83	5	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	mild_COVID-19_(asymptomatic)-CD4+_T_naive\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	KIAA0408 ARMH2 IL32 LOXL4 ATM	1.52e-05	167	83	5	78d264af390bd89942ffbb2991dc94f50756d4c9
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 IL32 SPTBN1 ENG CDH5	2.25e-05	181	83	5	4a225d9a6d113396c6b1d0a839bb4ca9c339a260
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 PIK3R6 SPTBN1 ENG CDH5	2.62e-05	187	83	5	0ef82111b9049cc7ee78d64d240e1f10ab14d6b6
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 SPTBN1 SFI1 ATM FBXO32	2.76e-05	189	83	5	e9df7ecd36bee1fedce23bb188c68a94fa60462c
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SPTBN5 IL32 PIK3R6 ENG CDH5	2.90e-05	191	83	5	e3fc5c92491b6e334abffbf085c00a0b5fa1aed2
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARMH2 IL32 SFI1 ATM FBXO32	3.05e-05	193	83	5	2901d7a9672a8cf70c9f1c752685b45e4d79ac70
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PIK3R6 PPP1R9A ENG CDH5 PTK2	3.05e-05	193	83	5	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	ARMH2 IL32 SFI1 ATM FBXO32	3.05e-05	193	83	5	beb862d38b88572836b0a797c8efef7a2492e0b9
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARMH2 IL32 SFI1 ATM FBXO32	3.05e-05	193	83	5	f4310faa13fc8ce99a217e2d1c9cc733683797a1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ARMH2 IL32 SFI1 ATM FBXO32	3.05e-05	193	83	5	f8af695457d2a0a911a5ac491742465864ebda37
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARMH2 IL32 SFI1 ATM FBXO32	3.05e-05	193	83	5	089aece40130034a89a5213be778f10b0787eeba
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature2_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MRC1 IL32 PIK3R6 ENG CDH5	3.13e-05	194	83	5	760f98bbcb669e599c389ef7892043eee3a05edf
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 SPTBN1 SFI1 ATM FBXO32	3.13e-05	194	83	5	a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 PIK3R6 SPTBN1 ENG CDH5	3.21e-05	195	83	5	ccfb80e3bfdf5304fa798e0a47b473955ecc0c6d
ToppCell	facs-Lung-nan-3m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 SPTBN1 ENG CDH5 STT3B	3.21e-05	195	83	5	7f9b7f15006610ad591063d90e90367bd6083c7f
ToppCell	(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	MRC1 ASAH2 SIRPA ENG CDH5	3.21e-05	195	83	5	6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	SPTBN1 XKR6 GRM8 CDH5 PTK2	3.29e-05	196	83	5	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPTBN5 IL32 SPTBN1 ENG CDH5	3.37e-05	197	83	5	b18f2c14d6720f6ae8520c0800356f4a57393ad3
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL32 SPTBN1 GRM8 ENG CDH5	3.45e-05	198	83	5	9ecf944984aade1bf902e3a92ea4d46a3696822f
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 SMG1 BPTF SFI1 ATM	3.53e-05	199	83	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	USP34 BPTF PPP1R9A SPTBN1 CDH5	3.62e-05	200	83	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	BPTF PPP1R9A SPTBN1 CDH5 PTK2	3.62e-05	200	83	5	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	BPTF PPP1R9A SPTBN1 CDH5 PTK2	3.62e-05	200	83	5	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Severe / Disease, condition lineage and cell class	IL32 SFI1 ATM FBXO32 EPHA1	3.62e-05	200	83	5	deeed668b129e66156b5f6abe1a07a9bf842a14d
ToppCell	COVID_vent\|World / Disease condition, Lineage, Cell class and subclass	IL32 CRELD2 TRAM2 TARS1 STT3B	3.62e-05	200	83	5	1d88e5cc4534073f27a7562e1c4b884bd67f09d9
ToppCell	LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MMAA ABCA2 ERAP2 TRAM2	1.12e-04	133	83	4	2ec3490cbf60152c3cece95eb566d749c9666517
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MMAA NUTM2D XKR6 NPHP4	1.82e-04	151	83	4	c1461d0dd622a081187eba77f454d2663df2732e
ToppCell	Leuk-UTI-Lymphocyte-T_NK-MAIT\|Leuk-UTI / Disease, Lineage and Cell Type	IL32 ABCA2 PPP1R9A XKR6	1.92e-04	153	83	4	ac3a1d1b5bf6009df818fd757dad7382d95c60dc
ToppCell	10x5'-Liver-Myeloid_Mac-Intestinal_macrophages\|Liver / Manually curated celltypes from each tissue	MRC1 CD163L1 CDH5 TLCD2	2.07e-04	156	83	4	9a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCell	mild_COVID-19_(asymptomatic)-CD4+_T_naive\|World / disease group, cell group and cell class (v2)	KIAA0408 ARMH2 LOXL4 ATM	2.12e-04	157	83	4	23879e65a6acc33d9aad096cd23604a77b0ac9c2
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 TPCN2 SIRPA MPPE1	2.33e-04	161	83	4	5a8698790f9aba796dd2b64af419055c60bd7de8
ToppCell	Healthy_donor-CD8+_T_naive\|World / disease group, cell group and cell class (v2)	DNAAF8 IL32 SFI1 ATM	2.33e-04	161	83	4	8a61395af33132783a0a37956c6f821aba5d3b1e
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RPTOR TAF1A ENG CDH5	2.68e-04	167	83	4	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IL32 NUTM2D ATM STT3B	2.74e-04	168	83	4	5e721268f0baa51d3f640f7f4c41db769ebef210
ToppCell	368C-Lymphocytic-ILC\|368C / Donor, Lineage, Cell class and subclass (all cells)	TPCN2 PIK3R6 ABCC10 EPHA1	2.93e-04	171	83	4	3b3143e4aa6520ee9c6b6f2482206ad3d8205d14
ToppCell	368C-Lymphocytic-ILC-ILC-2\|368C / Donor, Lineage, Cell class and subclass (all cells)	TPCN2 PIK3R6 ABCC10 EPHA1	2.93e-04	171	83	4	fd01076574dcc82bfd4a1538812500543b16794f
ToppCell	E12.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RTP3 PIK3R6 ENG CDH5	3.00e-04	172	83	4	ba99688e9f46671deccf824b1e77c6db0742d7df
ToppCell	E12.5-Endothelial-proliferative_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RTP3 PIK3R6 ENG CDH5	3.00e-04	172	83	4	2136170f6e1204734cec7dbf7b32e7d5179b92b5
ToppCell	droplet-Fat-SCAT-30m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	3.06e-04	173	83	4	eb58b0189e71e38d4f4f1cf544a82cde8d1c86bc
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK1 CRELD2 TRAM2 VARS1	3.13e-04	174	83	4	c92eec5a14ca5269673582dd115ead8516e64c3e
ToppCell	COVID-mDC1-\|COVID / Condition, Cell_class and T cell subcluster	SPTBN5 DNAH10 NUTM2D PTK2	3.20e-04	175	83	4	83a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA2 ILDR1 ATM ABCC10	3.20e-04	175	83	4	711ace94fa9a763c6ae48171a690953f25deebe4
ToppCell	COVID-mDC1\|COVID / Condition, Cell_class and T cell subcluster	SPTBN5 DNAH10 NUTM2D PTK2	3.20e-04	175	83	4	b9280444016e21c28131a61df65cc5c56d402412
ToppCell	facs-Heart-RV-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	3.27e-04	176	83	4	fb3d03f64592e1df1d9785d9f2e70938d7ff9ce8
ToppCell	facs-Heart-RV-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	3.27e-04	176	83	4	3270a36fc91a5583646ffeb70bfcbc5af7292aac
ToppCell	facs-Heart-RV-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	3.27e-04	176	83	4	99410c121f55adbc7fcc013c8fa8905a45dba76b
ToppCell	droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FJX1 HCN2 ENG PTK2	3.27e-04	176	83	4	e2b59a904c5c8f9c88e1e63788e9b6485f22edd0
ToppCell	droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FJX1 HCN2 ENG PTK2	3.27e-04	176	83	4	f931192e3cc65414e2245354f443473696cc7ce8
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 SFI1 FBXO32 EPHA1	3.34e-04	177	83	4	64b8f665fdaf975558af2ad7d9b54d206de8350c
ToppCell	tumor_Lung-Endothelial_cells-EPCs\|tumor_Lung / Location, Cell class and cell subclass	SPTBN5 SPTBN1 ENG CDH5	3.34e-04	177	83	4	f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5
ToppCell	metastatic_Lymph_Node-T/NK_cells-Naive_CD8+_T\|metastatic_Lymph_Node / Location, Cell class and cell subclass	ARMH2 IL32 ATM EPHA1	3.56e-04	180	83	4	16516dd9c78c27fc76f58d650de9851ffa0763e7
ToppCell	368C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TPCN2 PIK3R6 ABCC10 EPHA1	3.56e-04	180	83	4	eb5a57604c7f2ad256c300085dbf5069d0ae1ad0
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 SPTBN1 ENG CDH5	3.56e-04	180	83	4	97e0dcb7cfbba60a782824c5e23995058609fcd4
ToppCell	368C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TPCN2 PIK3R6 ABCC10 EPHA1	3.56e-04	180	83	4	ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	USP34 SMG1 SFI1 ATM	3.63e-04	181	83	4	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPTBN1 XKR6 GRM8 CDH5	3.71e-04	182	83	4	a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRC1 SIRPB1 SIRPA ENG	3.79e-04	183	83	4	103c4c4595d8daa677679fd2fa1e99cd398e56dd
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 PIK3R6 ENG CDH5	3.79e-04	183	83	4	52af3c943116073c8ddd207b664342960b88929b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 SFI1 ATM FBXO32	3.79e-04	183	83	4	f2ef110bf29b1a8276ef216238363e542db262c1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 DNAH10 SFI1 TEX11	3.87e-04	184	83	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 DNAH10 SFI1 TEX11	3.87e-04	184	83	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 DNAH10 SFI1 TEX11	3.87e-04	184	83	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ARMH2 PPFIBP2 TM4SF5 PAPPA	3.87e-04	184	83	4	607b55022de21ddb6a2d75e085df76df7abf6624
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRC1 SIRPB1 SIRPA ENG	3.95e-04	185	83	4	7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPTBN5 IL32 ENG CDH5	3.95e-04	185	83	4	0ab1be455f2cd883c9d1522ca78112c37833352e
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRC1 SIRPA ENG PLIN3	3.95e-04	185	83	4	68edb1bb03ed221d49e583123ca4de14252d7bc5
ToppCell	Endoth-Lymph\|World / shred by cell class for parenchyma	MRC1 CD163L1 SIRPA CDH5	3.95e-04	185	83	4	97a6c4cd00684d4085d36ef32f7dbb99563ed357
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-endo_bronchial_(8)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MRC1 PIK3R6 ENG CDH5	4.03e-04	186	83	4	0cc7504297fd0c97ea50e4b3ff58fcedc4c1cfaa
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-lymphatic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MRC1 IL32 PIK3R6 CDH5	4.03e-04	186	83	4	86b218a400f9c64f92b050f00b49f09647b17437
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MRC1 IL32 PIK3R6 CDH5	4.03e-04	186	83	4	f51c76b1c3c6c49e0ebc9a913d8413e0b6a04d80
ToppCell	facs-SCAT-Fat-24m-Endothelial-endothelial_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	4.11e-04	187	83	4	43e35ec995afd8780893de42ac4ee466794991d7
ToppCell	PND03\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PPP1R9A SPTBN1 SIRPA ACTR2	4.11e-04	187	83	4	b3fcb36d853adfdea7172c5591de06f027e50af3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN5 SPTBN1 ENG CDH5	4.11e-04	187	83	4	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	facs-SCAT-Fat-24m-Endothelial\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	4.11e-04	187	83	4	8ca9481d661626f6f0e1b61eb142b051192a9208
ToppCell	facs-SCAT-Fat-24m-Endothelial-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	4.11e-04	187	83	4	51336037dfd4bbe9fe9ce1e5b6b92d037156690c
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	SPTBN1 NUTM2D CDH5 PTK2	4.11e-04	187	83	4	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 PIK3R6 SPTBN1 CDH5	4.11e-04	187	83	4	25efb82afe863a853ecdd781ad89026c993aaa67
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RTP3 IL32 ENG CDH5	4.11e-04	187	83	4	d6765854154557794815514c0aa355bc74b8523e
ToppCell	Control-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	SPTBN1 XKR6 FBXO32 GRM8	4.19e-04	188	83	4	88b3415e33db81726dd29c1f50c886e057af50a0
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 SPTBN1 ENG CDH5	4.19e-04	188	83	4	0026c9479b30fb39daa91cfa220a88f9c9e65fe7
ToppCell	droplet-Fat-Scat-21m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	4.19e-04	188	83	4	8671fdbc4138e6f9559920779c98628ed80f0da3
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	IL32 SPTBN1 XKR6 CDH5	4.19e-04	188	83	4	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MRC1 PIK3R6 ENG CDH5	4.19e-04	188	83	4	b9c5d573fc5ab0f7f38c55d006f9576634b05462
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 PIK3R6 ENG CDH5	4.28e-04	189	83	4	9e58411e51019ca59e78d3e737d65d2bcbbea2be
ToppCell	facs-Heart-LV-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	4.28e-04	189	83	4	d424d2554595b2304219f7324406b401711af7c2
ToppCell	(2)_5-FU-(1)_VE-Cad+_vascular_cells\|(2)_5-FU / Stress and Cell class	MRC1 SIRPA ENG CDH5	4.28e-04	189	83	4	0f169b17bb26a812a5b0dcd6e29a3ca8415fd197
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	4.28e-04	189	83	4	393ec5954a12d6cf67bb435dcc34ff0b14c81e9f
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 PIK3R6 ENG CDH5	4.28e-04	189	83	4	b5fa3a619e3b554a1a45a551c9b6369075fe5615
ToppCell	facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	4.28e-04	189	83	4	bec57459ad4bab15b2532b57722549fec2e771fb
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 PPP1R9A DOCK7 PAPPA	4.28e-04	189	83	4	532aaf02b364c5c4f58a2021c7c21d86df3875c9
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 PPFIBP2 PAPPA FBXO32	4.28e-04	189	83	4	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	droplet-Fat-Scat-21m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	4.36e-04	190	83	4	d3e46cf800a07ca9b01c78192962d223b9785d05
ToppCell	(2)_5-FU-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	MRC1 SIRPA ENG CDH5	4.36e-04	190	83	4	6b391b8a3ffcbdec3acaf242bc52fc3fc9da77c8
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MRC1 FLCN ATM ENG	4.36e-04	190	83	4	63018acb7ad80415e861643162abdc2e55968ee4
ToppCell	droplet-Fat-Scat-21m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTP3 SPTBN1 ENG CDH5	4.36e-04	190	83	4	dd89ef1ecea20b2f6fbdc6cea4ca41b28b3ed822
ToppCell	PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating1_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	IL32 PIK3R6 ENG CDH5	4.36e-04	190	83	4	9a2244c3973aee7270646bf00db7727edb9decc5
ToppCell	(0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	MRC1 SIRPA ENG CDH5	4.36e-04	190	83	4	ff083168d609957d00888f31b3488d6d56c902b4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IL32 SFI1 ATM FBXO32	4.45e-04	191	83	4	d9a6f61fcda4f5352488f7f55cb9b57aeacc717f
Drug	Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A	USP34 ABCA2 SZT2 PPP1R9A SPTBN1 HAUS5 SFI1 ATM	4.91e-07	196	81	8	3441_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	TMEM120B SZT2 FLCN SFI1 ATM GRM8 EPHA1	5.97e-06	194	81	7	4763_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	USP34 ABCA2 TMEM120B SPTBN1 FLCN SFI1 EPHA1	7.06e-06	199	81	7	7439_UP
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A	USP34 C2CD3 POLG FLCN ATM ENG	5.68e-05	188	81	6	1865_DN
Drug	5186324; Up 200; 2uM; MCF7; HT_HG-U133A_EA	USP34 FLCN SFI1 EIF2AK1 TRAM2 GRM8	6.96e-05	195	81	6	900_UP
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	SPTBN1 HAUS5 FLCN SFI1 MUL1 EPHA1	7.16e-05	196	81	6	7409_UP
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	USP34 TMEM120B AP5Z1 FLCN ATM GRM8	7.16e-05	196	81	6	4697_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	CHRNA6 ABCA2 AP5Z1 ATM MPPE1 EPHA1	7.36e-05	197	81	6	3886_DN
Drug	rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA	USP34 ABCA2 TAF1A EIF2AK1 TRAM2 NPHP4	7.36e-05	197	81	6	1013_DN
Drug	Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	CHRNA6 SZT2 PPFIBP2 SPTBN1 SFI1 EIF2AK1	7.36e-05	197	81	6	5528_UP
Drug	estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A	SPTBN5 ABCA2 SZT2 ERAP2 SPTBN1 SFI1	7.36e-05	197	81	6	4465_UP
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	SPTBN5 SZT2 AP5Z1 SPTBN1 SFI1 MUL1	7.36e-05	197	81	6	2328_UP
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	USP34 TAF1A EIF2AK1 GRM8 MPPE1 MUL1	7.36e-05	197	81	6	6934_DN
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	USP34 PPP1R9A FLCN ATM MPPE1 EPHA1	7.36e-05	197	81	6	5025_DN
Drug	nifedipine; Down 200; 10uM; MCF7; HG-U133A	USP34 SPTBN1 HAUS5 ATM ENG MPPE1	7.36e-05	197	81	6	335_DN
Drug	Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A	HAUS5 FLCN ATM TRAM2 MPPE1 EPHA1	7.36e-05	197	81	6	1698_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	USP34 POLG TMEM115 EIF2AK1 GRM8 MUL1	7.57e-05	198	81	6	6929_DN
Drug	Brinzolamide [138890-62-7]; Down 200; 10.4uM; HL60; HG-U133A	USP34 CHRNA6 C2CD3 SFI1 SIRPA ENG	7.57e-05	198	81	6	1615_DN
Drug	Chenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A	USP34 TMEM120B AP5Z1 HAUS5 FLCN SFI1	7.57e-05	198	81	6	7433_UP
Drug	vinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A	ABCA2 FLCN DBR1 EIF2AK1 NPHP4 EPHA1	7.57e-05	198	81	6	7551_DN
Drug	Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A	USP34 SPTBN1 FLCN ATM MPPE1 MUL1	7.57e-05	198	81	6	6841_DN
Drug	Vigabatrin [60643-86-9]; Up 200; 31uM; MCF7; HT_HG-U133A	CHRNA6 PPFIBP2 AP5Z1 SPTBN1 PAPPA GRM8	7.78e-05	199	81	6	5415_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	ABCA2 HAUS5 DBR1 EIF2AK1 GRM8 MUL1	7.78e-05	199	81	6	6942_DN
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A	USP34 ABCA2 SPTBN1 FLCN SFI1 ATM	7.78e-05	199	81	6	2214_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HG-U133A	POLG SPTBN1 SFI1 TRAM2 MPPE1 EPHA1	7.78e-05	199	81	6	348_DN
Drug	Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A	USP34 FLCN TM4SF5 SFI1 NPHP4 ABCC10	8.00e-05	200	81	6	7404_UP
Drug	6-thioguanine; Up 200; 10uM; MCF7; HG-U133A	SPTBN5 SZT2 POLG SFI1 GRM8 MPPE1	8.00e-05	200	81	6	642_UP
Disease	level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum	SIRPB1 SIRPA	7.26e-06	2	80	2	OBA_2040362
Disease	age-related hearing impairment	FBXL13 SPTBN1 ILDR1 SFI1 PTK2 ABCC10	2.54e-04	324	80	6	EFO_0005782
Disease	signal-regulatory protein beta-1 measurement	SIRPB1 SIRPA	2.58e-04	9	80	2	EFO_0802069
Disease	triglycerides in small VLDL measurement	BPTF DNAH10 DOCK7	6.17e-04	61	80	3	EFO_0022145
Disease	phospholipids in large VLDL measurement	BPTF DNAH10 DOCK7	6.47e-04	62	80	3	EFO_0022169
Disease	coronary artery disease (is_marker_for)	PAPPA ENG CDH5	8.11e-04	67	80	3	DOID:3393 (is_marker_for)
Disease	hearing loss	SPTBN1 ILDR1 PTK2	8.11e-04	67	80	3	EFO_0004238
Disease	Paroxysmal atrial fibrillation	USP34 DNAH10 FBXO32 PTK2	8.70e-04	156	80	4	C0235480
Disease	familial atrial fibrillation	USP34 DNAH10 FBXO32 PTK2	8.70e-04	156	80	4	C3468561
Disease	Persistent atrial fibrillation	USP34 DNAH10 FBXO32 PTK2	8.70e-04	156	80	4	C2585653
Disease	Atrial Fibrillation	USP34 DNAH10 FBXO32 PTK2	9.56e-04	160	80	4	C0004238
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	BPTF DNAH10 DOCK7 TM4SF5	1.10e-03	166	80	4	EFO_0004530, EFO_0004611
Disease	neuroimaging measurement, brain volume measurement	USP34 MRC1 BPTF PAPPA XKR6	1.10e-03	286	80	5	EFO_0004346, EFO_0006930
Disease	leukemia (implicated_via_orthology)	MEIS3P2 ATM	1.20e-03	19	80	2	DOID:1240 (implicated_via_orthology)
Disease	mitochondrial DNA measurement	TMEM120B POLG SIRPB1 SIRPA VARS1	2.00e-03	328	80	5	EFO_0006312
Disease	endometriosis (is_marker_for)	IL32 PTK2	2.09e-03	25	80	2	DOID:289 (is_marker_for)
Disease	mean arterial pressure	FBXL13 SZT2 ERAP2 RPTOR XKR6 ABCC10	2.37e-03	499	80	6	EFO_0006340
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	BPTF DNAH10 DOCK7 XKR6	2.41e-03	206	80	4	EFO_0004612, EFO_0020947
Disease	lung small cell carcinoma (is_implicated_in)	ATM PTK2	2.62e-03	28	80	2	DOID:5409 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
MQGRRDTDHWLRSNW	EPHA1	71	P21709
NWLVERWHFIMLNDT	PRMT9	146	Q6P2P2
HLQMLAAENWSGWTE	ARMH2	201	H3BNL8
QWLNVQAFSMLRAWL	AP5Z1	236	O43299
RWEWKQTACHLNMEA	CD163L1	771	Q9NR16
WASHRANWIKAVQMC	BPTF	926	Q12830
THRRQKRDWIWNQMH	CDH5	41	P33151
WLIDANHNMQIWTTG	ENG	261	P17813
NGIVRNWDDMKHLWD	ACTR2	76	P61160
FSRHEEELQHWWQMQ	CCDC27	306	Q2M243
NLLLQAWMRVHSWAS	CDRT15	161	Q96T59
SLLLMQATRNAADWW	ABCC10	891	Q5T3U5
VLMNRQWGTVCDHRW	LOXL4	326	Q96JB6
WHVLMGNQVIWKSRD	FLCN	366	Q8NFG4
AHQWVDMTDVTVWLN	ASAH2	426	Q9NR71
EMIWAANQHNWIDCS	KIAA1109	531	Q2LD37
WQMERAFQTALWLLQ	MPPE1	96	Q53F39
NRADLVINEVMWWDH	ILDR1	126	Q86SU0
WRNAHKRISSQMVVW	POLG	801	P54098
MDLHKQWENTETNWH	KIAA0408	1	Q6ZU52
LQEHKMVWNRTTHLW	MUL1	96	Q969V5
MVWNRTTHLWNDCSK	MUL1	101	Q969V5
WMWNLIQESVLEHFR	MMAA	366	Q8IVH4
QWQQEWHSLRVSLQA	GDPD2	141	Q9HCC8
QDQRSLWCWDLLHMK	HAUS5	526	O94927
NLVTMEWWTHLRLNE	NPEPPSL1	361	A6NEC2
LQENWDNVKHAWSPM	PAPPA	286	Q13219
WTNQLHLKVEDMQWA	GRM8	491	O00222
VQWSNHRVMEWLRSV	PPFIBP2	716	Q8ND30
SNLACMHMVRWAVWN	NPHP4	381	O75161
ATNIMRAWLFQHLWH	MEIS3P2	256	A8K0S8
QWAQVQEELRAAHWT	FJX1	221	Q86VR8
VNQIMETNLWLRHIW	CHRNA6	76	Q15825
QAAWRNMQWDHCTSV	ATM	2101	Q13315
RWFQAMLQRLQTWWH	IL32	156	P24001
PMIEHWWNSNLTFQI	C2CD3	631	Q4AC94
NLRWRKDMTHWRQNT	DOCK7	1441	Q96N67
HIQMQLCELSLWDWI	EIF2AK1	381	Q9BQI3
WWAADHRQVQDRMVP	DNAAF8	291	Q8IYS4
MGLNNAVHWVAWFIT	ABCA2	741	Q9BZC7
VNHAWMLMTQLNSLW	FBXL13	181	Q8NEE6
VMLHRRLWNNFDWDL	MAN2B2	791	Q9Y2E5
ELAHQWFGNLVTMEW	ERAP2	371	Q6P179
RLWNMPENNGLHARW	DBR1	301	Q9UK59
WVYRMETILHWQQQL	FBXO32	196	Q969P5
NQMLEAQEEHLEAWW	CRELD2	91	Q6UXH1
QWLMLQNCHLLVKWL	DNAH10	3931	Q8IVF4
RNCWVSINGMVNHSW	HCN2	396	Q9UL51
FRWHNSQWLEMVESR	KIFAP3	676	Q92845
TMSWNDINCEHLNNW	MRC1	761	P22897
EGLWRAMREWQHTSN	NUTM2D	306	Q5VT03
GLWQAMREWQHTSNF	NUTM2F	256	A1L443
NWASAQVLVLFHMNW	RTP3	61	Q9BQQ7
NIFNSRLWMTSGHWQ	TARS1	376	P26639
NAWAVTNHFSMWLAA	TAS2R19	86	P59542
NAWVVTNHFSMWLAA	TAS2R50	86	P59544
LPEAHQRTWHAWMDN	VARS1	701	P26640
LSMDANSWQRWLHMH	SZT2	566	Q5T011
NSWQRWLHMHRLVLI	SZT2	571	Q5T011
WFMWHQQAAARHQEQ	SFI1	556	A8K8P3
RLQAWLQHMGCEHWV	THAP8	36	Q8NA92
NHLDLTVEGFQSWMW	TMEM120B	251	A0PK00
MGNHLAWVQEEWNSR	TAF1A	361	Q15573
TDSWNHRPQEIAMWQ	PTK2	771	Q05397
VEGQEKLHQMWLSWN	PLIN3	291	O60664
PALQSNQGMWRWSLH	PIK3R6	26	Q5UE93
LWDELWLGVLLQQHM	SMG1	1961	Q96Q15
NWMSWLLVNVSAHRD	SIRPA	311	P78324
HAMWQAWDLAVDICL	RPTOR	376	Q8N122
LRHRQQEVAESWWQL	SPTBN5	2441	Q9NRC6
WMSWLLVNVSAHRDD	SIRPB1	311	Q5TFQ8
WNELHKMWENRQNLL	SPTBN1	1151	Q01082
MQRWTLWAAAFLTLH	CLEC19A	1	Q6UXS0
WMSWLLVNTCAHRDD	SIRPB1	311	O00241
HVWVMNLRWKNSNSF	TMEM138	96	Q9NPI0
WQSVIHLLQMGQVWR	XKR6	241	Q5GH73
LGWMSLWLFRQHHQV	TLCD2	181	A6NGC4
LRQNTDEHARVMSWW	STT3B	591	Q8TCJ2
AAQAWLMWRFIHSQL	TRAM2	301	Q15035
NFWIWTLATHGLMEQ	TMEM115	56	Q12893
ESMNWLHNILWRQAA	TEX11	411	Q8IYF3
SVKWRGHLIAWANNM	VPS41	176	P49754
IEAMVQLMLHFRWNW	TAS1R2	191	Q8TE23
QLMLHFRWNWIIVLV	TAS1R2	196	Q8TE23
SWTNTNHLSLQVWLM	TM4SF5	36	O14894
ELLEWIWHDNMQFLQ	USP34	2256	Q70CQ2
AHSWVLQNMENWVER	USP34	2656	Q70CQ2
AALVTLWNLMVVNNW	TPCN2	641	Q8NHX9
QEWSVQQVSHWLMSL	PPP1R9A	986	Q9ULJ8
NLTWRDMQHLVVWTS	PCSK1	401	P29120